Affordable Access

Exquisite sensitivity of TP53 mutant and basal breast cancers to a dose-dense epirubicin-cyclophosphamide regimen.

Authors
Type
Published Article
Journal
PLoS Medicine
1549-1676
Publisher
Public Library of Science
Publication Date
Volume
4
Issue
3
Identifiers
PMID: 17388661
Source
Medline

Abstract

There are no comments yet on this publication. Be the first to share your thoughts.

Statistics

Seen <100 times
0 Comments